Apyx Medical Co. (NASDAQ:APYX) Short Interest Update

Apyx Medical Co. (NASDAQ:APYX) was the recipient of a significant decrease in short interest in September. As of September 15th, there was short interest totalling 243,900 shares, a decrease of 8.0% from the August 31st total of 265,100 shares. Approximately 0.8% of the shares of the company are short sold. Based on an average trading volume of 35,200 shares, the short-interest ratio is currently 6.9 days.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. Kingsview Wealth Management LLC grew its position in Apyx Medical by 156.7% during the first quarter. Kingsview Wealth Management LLC now owns 31,028 shares of the company’s stock worth $42,000 after buying an additional 18,943 shares in the last quarter. RPg Family Wealth Advisory LLC bought a new stake in shares of Apyx Medical during the 2nd quarter valued at about $101,000. Perkins Capital Management Inc. grew its holdings in shares of Apyx Medical by 7.0% during the first quarter. Perkins Capital Management Inc. now owns 228,500 shares of the company’s stock worth $311,000 after purchasing an additional 15,000 shares in the last quarter. Rathbones Group PLC grew its holdings in shares of Apyx Medical by 148.0% during the second quarter. Rathbones Group PLC now owns 251,334 shares of the company’s stock worth $337,000 after purchasing an additional 150,000 shares in the last quarter. Finally, Commonwealth Equity Services LLC bought a new position in shares of Apyx Medical in the first quarter worth approximately $676,000. Institutional investors own 55.33% of the company’s stock.

Apyx Medical Trading Up 3.3 %

Shares of APYX opened at $1.24 on Tuesday. Apyx Medical has a twelve month low of $0.97 and a twelve month high of $3.46. The stock has a market cap of $42.96 million, a PE ratio of -1.85 and a beta of 1.20. The company has a quick ratio of 4.45, a current ratio of 5.33 and a debt-to-equity ratio of 2.26. The business’s 50-day moving average price is $1.24 and its 200-day moving average price is $1.38.

Apyx Medical (NASDAQ:APYX) last posted its earnings results on Thursday, August 8th. The company reported ($0.19) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.01). Apyx Medical had a negative return on equity of 105.45% and a negative net margin of 57.86%. The firm had revenue of $12.15 million for the quarter, compared to the consensus estimate of $12.67 million. During the same period last year, the company posted ($0.11) EPS. On average, equities analysts forecast that Apyx Medical will post -0.69 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, JMP Securities reiterated a “market perform” rating on shares of Apyx Medical in a research report on Monday, September 16th.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.